|Articles|July 27, 2015
Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting
Author(s)Janet Freeman-Daily
Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).
Advertisement
We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Kidney Cancer Disparities Persist Among American Indian and Alaskan Native Patients
2
TKIs Take Lead After Immunotherapy in Metastatic Kidney Cancer
3
Higher BMI Linked to Better Survival in Localized Kidney Cancer
4
Breaking Down Advancements in Prostate Cancer Care
5
